Buprenorphine Test Evidence
Has Caused a False Positive
Amisulpride
Source Birch et al., J Anal Toxicol 2013
What It Found
- Two patients receiving amisulpride had unconfirmed buprenorphine screens.
- LC-MS/MS detected amisulpride and excluded buprenorphine and its metabolites.
- Laboratory testing documented weak cross-reactivity.
Keep in Mind
- The reported psychiatric treatment exposure is not directly comparable to a single IV antiemetic dose of amisulpride.
Test Studied
- Thermo CEDIA buprenorphine
Loperamide
Source Geno et al., J Appl Lab Med 2022
What It Found
- The N-desmethyl metabolite of loperamide produced positive buprenorphine screens above 12.2 mg/L in spiked urine.
- A clinical specimen contained an interfering concentration.
Keep in Mind
- Evidence concerns high concentrations and a specific metabolite.
- A usual antidiarrheal dose is not established as a cause.
Test Studied
- Thermo CEDIA buprenorphine
Stevia
Source Plattner et al., J Anal Toxicol 2021
What It Found
- A study of unexpected screens investigated steviol glucuronide, a urinary metabolite of stevia sweeteners.
- It cross-reacted above 15 mg/L.
Keep in Mind
- This food-additive finding pertains to the Buprenorphine II reagent.
- It does not imply that every stevia product or serving causes a positive.
Test Studied
- Thermo CEDIA Buprenorphine II
Benzylpiperazine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Benzylpiperazine spike of 29,000 ng/mL, the mean assay response was 6.1 ng/mL equivalent (0.02% cross-reactivity), above the 5 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Buprenorphine urine assay, cutoff 5 ng/mL
Butylone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Butylone spike of 29,000 ng/mL, the mean assay response was 6 ng/mL equivalent (0.02% cross-reactivity), above the 5 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Buprenorphine urine assay, cutoff 5 ng/mL
Ceftaroline fosamil
Source Hughey and Colby, Clin Chem 2019
What It Found
- In a clinical-records study followed by laboratory testing, added ceftaroline fosamil produced a presumptive buprenorphine result at an estimated 681.5 micrograms/mL.
Keep in Mind
- This experiment establishes analytical reactivity.
- It did not establish how often prescribed doses lead to this urine concentration or a positive patient result.
Test Studied
- Thermo CEDIA buprenorphine, 5 ng/mL
Chloroquine
Source Melanson et al., J Anal Toxicol 2012
What It Found
- Laboratory comparison of CEDIA and the Lin-Zhi buprenorphine assay identified chloroquine interference with CEDIA.
Keep in Mind
- No clinical event frequency or transferable cutoff was established for people taking chloroquine.
Test Studied
- Microgenics CEDIA buprenorphine
Donepezil
Source Hughey and Colby, Clin Chem 2019
What It Found
- In a clinical-records study followed by laboratory testing, added donepezil produced a presumptive buprenorphine result at an estimated 709.6 micrograms/mL.
Keep in Mind
- This experiment establishes analytical reactivity.
- It did not establish how often prescribed doses lead to this urine concentration or a positive patient result.
Test Studied
- Thermo CEDIA buprenorphine, 5 ng/mL
Flephedrone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a 4-Fluoromethcathinone spike of 27,000 ng/mL, the mean assay response was 5.8 ng/mL equivalent (0.02% cross-reactivity), above the 5 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Buprenorphine urine assay, cutoff 5 ng/mL
Hydroxychloroquine
Source Melanson et al., J Anal Toxicol 2012
What It Found
- A method-comparison study identified interference with this reagent.
Test Studied
- Microgenics CEDIA buprenorphine
Source Radke et al., Toxicol Rep 2019
What It Found
- Hydroxychloroquine also affected selected assays at high concentrations in an overdose investigation.
Keep in Mind
- An absorbance alarm on an oxycodone assay does not show an oxycodone false positive.
Both sources Melanson et al., J Anal Toxicol 2012 Radke et al., Toxicol Rep 2019
Keep in Mind
- The nature of the effect differs by test.
Levofloxacin
Source Colby et al., Clin Biochem 2019
What It Found
- When levofloxacin was added to drug-free urine at concentrations considered achievable during treatment, this assay produced a presumptive positive.
Keep in Mind
- This differs from the negative dedicated oxycodone and methadone assays tested in the same experiment.
Test Studied
- Thermo CEDIA buprenorphine
Methoxetamine
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Methoxetamine spike of 28,000 ng/mL, the mean assay response was 5.9 ng/mL equivalent (0.02% cross-reactivity), above the 5 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Buprenorphine urine assay, cutoff 5 ng/mL
Methylenedioxypyrovalerone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Methylenedioxypyrovalerone spike of 21,000 ng/mL, the mean assay response was 6 ng/mL equivalent (0.03% cross-reactivity), above the 5 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Buprenorphine urine assay, cutoff 5 ng/mL
Procainamide
Source Hughey and Colby, Clin Chem 2019
What It Found
- In a clinical-records study followed by laboratory testing, added procainamide produced a presumptive buprenorphine result at an estimated 92.8 micrograms/mL.
- An N-acetyl hydroxy metabolite also reacted.
Keep in Mind
- This experiment establishes analytical reactivity.
- It did not establish how often prescribed doses lead to this urine concentration or a positive patient result.
Test Studied
- Thermo CEDIA buprenorphine, 5 ng/mL
Propafenone
Source Hughey and Colby, Clin Chem 2019
What It Found
- In a clinical-records study followed by laboratory testing, added propafenone produced a presumptive buprenorphine result at an estimated 180.7 micrograms/mL.
Keep in Mind
- This experiment establishes analytical reactivity.
- It did not establish how often prescribed doses lead to this urine concentration or a positive patient result.
Test Studied
- Thermo CEDIA buprenorphine, 5 ng/mL
Rotigotine
Source Hughey and Colby, Clin Chem 2019
What It Found
- In a clinical-records study followed by laboratory testing, added rotigotine produced a presumptive buprenorphine result at an estimated 0.13 micrograms/mL.
Keep in Mind
- This experiment establishes analytical reactivity.
- It did not establish how often prescribed doses lead to this urine concentration or a positive patient result.
Test Studied
- Thermo CEDIA buprenorphine, 5 ng/mL
Sulpiride
Source Birch et al., J Anal Toxicol 2013
What It Found
- The investigators demonstrated low but measurable analytical cross-reactivity with sulpiride.
- High urinary levels relative to the assay cutoff could make it relevant.
Keep in Mind
- The two patients with mass-spectrometry confirmation described in the abstract were receiving amisulpride.
- The sulpiride evidence presented here is analytical.
Test Studied
- Thermo CEDIA buprenorphine
Trimethoprim
Source Hughey and Colby, Clin Chem 2019
What It Found
- In a clinical-records study followed by laboratory testing, added trimethoprim produced a presumptive buprenorphine result at an estimated 47.2 micrograms/mL.
- Its frequent partner sulfamethoxazole did not react in this experiment.
Keep in Mind
- This experiment establishes analytical reactivity.
- It did not establish how often prescribed doses lead to this urine concentration or a positive patient result.
Test Studied
- Thermo CEDIA buprenorphine, 5 ng/mL
Depends on the Brand of Test
Codeine
Source Berg et al., Subst Abuse Rehabil 2015
What It Found
- One healthy volunteer screened positive after a therapeutic 60 mg codeine dose with acetaminophen.
- Spiking and patient urine data implicated codeine and its metabolites, which can have additive effects.
Keep in Mind
- A higher cutoff improved specificity in the study.
- Acetaminophen was part of the formulation, not the identified cross-reactant.
Source Cirimele et al., J Anal Toxicol 2003
What It Found
- No cross-reaction was reported with Codeine at 1 or 10 mg/L in the Singlestep assay.
Keep in Mind
- These reagent-specific challenges do not predict responses on other buprenorphine assays.
Test Studied
- Microgenics Singlestep urine buprenorphine ELISA
Source Wang et al., J Anal Toxicol 2007
What It Found
- The recombinant assay showed less than 1% relative cross-reactivity with Codeine.
Keep in Mind
- A small percentage response cannot be converted to a positive concentration without the assay’s calibration and challenge conditions.
Test Studied
- A recombinant G6PDH-based homogeneous urine buprenorphine immunoassay
Source Cirimele et al., Forensic Sci Int 2004
What It Found
- The IDS validation reports no cross-reactivity with Codeine.
Keep in Mind
- The IDS assay was evaluated in human urine, blood and hair.
- The abstract does not separately assign a challenge matrix for each compound.
- It does not exclude a result on other buprenorphine reagents.
Test Studied
- IDS One-Step buprenorphine ELISA
2 sources Berg et al., Subst Abuse Rehabil 2015 Pavlic et al., Int J Legal Med 2005
Test Studied
- Thermo CEDIA buprenorphine, especially 5 ng/mL cutoff
Dihydrocodeine
Source Pavlic et al., Int J Legal Med 2005
What It Found
- Dihydrocodeine reacted above 60 mg/L in the reported CEDIA assay.
Source Miller et al., J Anal Toxicol 2006
What It Found
- An Immunalysis microplate ELISA did not react at the lower concentrations studied, up to 10 mg/L.
Source Cirimele et al., J Anal Toxicol 2003
What It Found
- No cross-reaction was reported with Dihydrocodeine at 1 or 10 mg/L in the Singlestep assay.
Keep in Mind
- These reagent-specific challenges do not predict responses on other buprenorphine assays.
Test Studied
- Microgenics Singlestep urine buprenorphine ELISA
Source Böttcher and Beck, J Anal Toxicol 2005
What It Found
- Unconfirmed buprenorphine screens occurred in patients who had been prescribed dihydrocodeine.
Keep in Mind
- This is clinical evidence for the CEDIA reagent; the Singlestep ELISA gave a different result in fortified urine.
Test Studied
- Microgenics CEDIA buprenorphine assay, 5 ng/mL cutoff, with GC-MS comparison
Source Wang et al., J Anal Toxicol 2007
What It Found
- The recombinant assay showed less than 1% relative cross-reactivity with Dihydrocodeine.
Keep in Mind
- A small percentage response cannot be converted to a positive concentration without the assay’s calibration and challenge conditions.
Test Studied
- A recombinant G6PDH-based homogeneous urine buprenorphine immunoassay
Source Cirimele et al., Forensic Sci Int 2004
What It Found
- The validation reports no cross-reaction with Dihydrocodeine at 1 or 10 mg/L.
Keep in Mind
- The IDS assay was evaluated in human urine, blood and hair.
- The abstract does not separately assign a challenge matrix for each compound.
- It does not exclude a result on other buprenorphine reagents.
Test Studied
- IDS One-Step buprenorphine ELISA
2 sources Pavlic et al., Int J Legal Med 2005 Miller et al., J Anal Toxicol 2006
Keep in Mind
- Different assays and concentrations were tested.
- There is no patient risk estimate.
2 sources Pavlic et al., Int J Legal Med 2005 Böttcher and Beck, J Anal Toxicol 2005
Test Studied
- Microgenics CEDIA buprenorphine (5 ng/mL cutoff)
Morphine
Source Tenore, J Addict Dis 2012
What It Found
- Repeated screens became positive with high-dose morphine, negative when it was stopped, then positive again when restarted.
- GC-MS excluded buprenorphine.
Test Studied
- Clinical EIA
Source Pavlic et al., Int J Legal Med 2005
What It Found
- An earlier analytical study demonstrated morphine cross-reactivity.
Source Cirimele et al., J Anal Toxicol 2003
What It Found
- No cross-reaction was reported with Morphine at 1 or 10 mg/L in the Singlestep assay.
Keep in Mind
- These reagent-specific challenges do not predict responses on other buprenorphine assays.
Test Studied
- Microgenics Singlestep urine buprenorphine ELISA
Source Wang et al., J Anal Toxicol 2007
What It Found
- The recombinant assay showed less than 1% relative cross-reactivity with Morphine.
Keep in Mind
- A small percentage response cannot be converted to a positive concentration without the assay’s calibration and challenge conditions.
Test Studied
- A recombinant G6PDH-based homogeneous urine buprenorphine immunoassay
Source Cirimele et al., Forensic Sci Int 2004
What It Found
- The IDS validation reports no cross-reactivity with Morphine.
Keep in Mind
- The IDS assay was evaluated in human urine, blood and hair.
- The abstract does not separately assign a challenge matrix for each compound.
- It does not exclude a result on other buprenorphine reagents.
Test Studied
- IDS One-Step buprenorphine ELISA
Source Schubert et al., J Anal Toxicol 2019
What It Found
- In an opioid-maintenance cohort including high-dose morphine, the newer reagent had substantially better specificity.
- Its one borderline unconfirmed result had no identified interferent.
Keep in Mind
- The 21 first-generation false positives were attributed collectively to opiate cross-reactivity, without proving morphine alone in each specimen.
Test Studied
- First-generation CEDIA buprenorphine (5 ng/mL) and CEDIA Buprenorphine II (10 ng/mL)
3 sources Tenore, J Addict Dis 2012 Berg et al., Subst Abuse Rehabil 2015 Pavlic et al., Int J Legal Med 2005
Keep in Mind
- High urine concentrations or combined opioid metabolites can matter.
Test Studied
- Microgenics CEDIA buprenorphine
2 sources Tenore, J Addict Dis 2012 Pavlic et al., Int J Legal Med 2005
Keep in Mind
- The findings are not a frequency estimate for standard doses.
Tramadol
Source Shaikh et al., J Anal Toxicol 2008
What It Found
- Among 29 urine samples from patients on tramadol, seven positive buprenorphine screens were shown false by LC-MS/MS.
- No false positives were found on ACON at 10 ng/mL or CEDIA at 20 ng/mL.
Keep in Mind
- Three screen-positive specimens lacked enough urine for confirmation.
- Reactivity depends on the device and cutoff.
Tests Studied
- CEDIA at 5 versus 20 ng/mL
- QuikStrip, ABMC and ACON point-of-care devices
Methadone
Source Pavlic et al., Int J Legal Med 2005
What It Found
- A CEDIA study found interference above 320 mg/L of methadone.
Keep in Mind
- This was an exceptionally high analytical concentration and does not imply routine maintenance treatment will trigger this test.
Test Studied
- Microgenics CEDIA buprenorphine
Source Miller et al., J Anal Toxicol 2006
What It Found
- A different ELISA did not react at its tested upper concentration of 10 mg/L.
- EDDP, its metabolite, was also tested without a reaction.
Source Cirimele et al., J Anal Toxicol 2003
What It Found
- No cross-reaction was reported with Methadone at 1 or 10 mg/L in the Singlestep assay.
Keep in Mind
- These reagent-specific challenges do not predict responses on other buprenorphine assays.
Test Studied
- Microgenics Singlestep urine buprenorphine ELISA
Source Cirimele et al., Forensic Sci Int 2004
What It Found
- The IDS validation reports no cross-reactivity with Methadone.
Keep in Mind
- The IDS assay was evaluated in human urine, blood and hair.
- The abstract does not separately assign a challenge matrix for each compound.
- It does not exclude a result on other buprenorphine reagents.
Test Studied
- IDS One-Step buprenorphine ELISA
Methylone
Source Beck et al., Drug Test Anal 2014
What It Found
- At a Methylone spike of 23,000 ng/mL, the mean assay response was 3.7 ng/mL equivalent (0.02% cross-reactivity), below the 5 ng/mL cutoff.
Keep in Mind
- This is a mean laboratory signal at the stated concentration.
- The separate clinical urine findings can include metabolites or coexposures.
Test Studied
- CEDIA Buprenorphine urine assay, cutoff 5 ng/mL
The Test Is Made to Find It
Buprenorphine
All 4 sources Melanson et al., J Anal Toxicol 2012 Miller et al., J Anal Toxicol 2006 Debrabandere et al., Analyst 1993 Wang et al., J Anal Toxicol 2007
What It Found
- Prescribed buprenorphine can appropriately trigger this test.
- Suboxone contains two active ingredients: buprenorphine explains expected buprenorphine detection; the separate naloxone entry describes interference on some other tests.
Keep in Mind
- The result alone does not measure adherence to a particular dose.
Test Studied
- Dedicated buprenorphine screen
Source Debrabandere et al., Analyst 1993
What It Found
- The assay antibody showed up to about 90% reactivity with norbuprenorphine, the N-dealkylated metabolite, while its glucuronide responses were low.
Keep in Mind
- Different buprenorphine assays recognize the metabolites to different degrees.
Test Studied
- Historical urine radioimmunoassay and HPLC
Source Wang et al., J Anal Toxicol 2007
What It Found
- The antibody recognized free buprenorphine and norbuprenorphine nearly equally.
Keep in Mind
- This is reagent-specific.
- Other assays respond differently to the metabolite.
Test Studied
- Recombinant G6PDH-based homogeneous urine buprenorphine immunoassay
2 sources Debrabandere et al., Analyst 1993 Wang et al., J Anal Toxicol 2007
Keep in Mind
- Reagents vary in the extent to which they recognize parent drug and metabolites.
Tested: No False Positive Found
Cytarabine
Source Hughey and Colby, Clin Chem 2019
What It Found
- An association in medical records did not reproduce when cytarabine was added to drug-free urine.
- Concomitant levofloxacin was common.
Keep in Mind
- A prescribing association alone is insufficient evidence of direct interference.
Test Studied
- Thermo CEDIA buprenorphine, 5 ng/mL
Dextromethorphan
Source Cirimele et al., J Anal Toxicol 2003
What It Found
- No cross-reaction was reported with Dextromethorphan at 1 or 10 mg/L in the Singlestep assay.
Keep in Mind
- These reagent-specific challenges do not predict responses on other buprenorphine assays.
Test Studied
- Microgenics Singlestep urine buprenorphine ELISA
Source Cirimele et al., Forensic Sci Int 2004
What It Found
- The validation reports no cross-reaction with Dextromethorphan at 1 or 10 mg/L.
Keep in Mind
- The IDS assay was evaluated in human urine, blood and hair.
- The abstract does not separately assign a challenge matrix for each compound.
- It does not exclude a result on other buprenorphine reagents.
Test Studied
- IDS One-Step buprenorphine ELISA
Dextromoramide
Source Cirimele et al., J Anal Toxicol 2003
What It Found
- No cross-reaction was reported with Dextromoramide at 1 or 10 mg/L in the Singlestep assay.
Keep in Mind
- These reagent-specific challenges do not predict responses on other buprenorphine assays.
Test Studied
- Microgenics Singlestep urine buprenorphine ELISA
Source Cirimele et al., Forensic Sci Int 2004
What It Found
- The validation reports no cross-reaction with Dextromoramide at 1 or 10 mg/L.
Keep in Mind
- The IDS assay was evaluated in human urine, blood and hair.
- The abstract does not separately assign a challenge matrix for each compound.
- It does not exclude a result on other buprenorphine reagents.
Test Studied
- IDS One-Step buprenorphine ELISA
Ethylmorphine
Source Cirimele et al., J Anal Toxicol 2003
What It Found
- No cross-reaction was reported with Ethylmorphine at 1 or 10 mg/L in the Singlestep assay.
Keep in Mind
- These reagent-specific challenges do not predict responses on other buprenorphine assays.
Test Studied
- Microgenics Singlestep urine buprenorphine ELISA
Source Cirimele et al., Forensic Sci Int 2004
What It Found
- The validation reports no cross-reaction with Ethylmorphine at 1 or 10 mg/L.
Keep in Mind
- The IDS assay was evaluated in human urine, blood and hair.
- The abstract does not separately assign a challenge matrix for each compound.
- It does not exclude a result on other buprenorphine reagents.
Test Studied
- IDS One-Step buprenorphine ELISA
Heroin
Source Cirimele et al., J Anal Toxicol 2003
What It Found
- No cross-reaction was reported with 6-monoacetylmorphine, the heroin metabolite at 1 or 10 mg/L in the Singlestep assay.
Test Studied
- Microgenics Singlestep urine buprenorphine ELISA
Source Cirimele et al., Forensic Sci Int 2004
What It Found
- The IDS validation reported no cross-reaction with 6-monoacetylmorphine, the primary heroin metabolite, at 1 or 10 mg/L.
Keep in Mind
- The IDS assay was evaluated in human urine, blood and hair.
- The abstract does not separately assign a challenge matrix for each compound.
- It does not exclude a result on other buprenorphine reagents.
Test Studied
- IDS One-Step buprenorphine ELISA
Both sources Cirimele et al., J Anal Toxicol 2003 Cirimele et al., Forensic Sci Int 2004
Keep in Mind
- Only the heroin metabolite 6-acetylmorphine (6-MAM) was tested.
- The experiment gives no direct result for the parent drug.
Pholcodine
Source Cirimele et al., J Anal Toxicol 2003
What It Found
- No cross-reaction was reported with Pholcodine at 1 or 10 mg/L in the Singlestep assay.
Keep in Mind
- These reagent-specific challenges do not predict responses on other buprenorphine assays.
Test Studied
- Microgenics Singlestep urine buprenorphine ELISA
Source Cirimele et al., Forensic Sci Int 2004
What It Found
- The validation reports no cross-reaction with Pholcodine at 1 or 10 mg/L.
Keep in Mind
- The IDS assay was evaluated in human urine, blood and hair.
- The abstract does not separately assign a challenge matrix for each compound.
- It does not exclude a result on other buprenorphine reagents.
Test Studied
- IDS One-Step buprenorphine ELISA
Propoxyphene
Source Cirimele et al., J Anal Toxicol 2003
What It Found
- No cross-reaction was reported with Propoxyphene at 1 or 10 mg/L in the Singlestep assay.
Keep in Mind
- These reagent-specific challenges do not predict responses on other buprenorphine assays.
Test Studied
- Microgenics Singlestep urine buprenorphine ELISA
Source Cirimele et al., Forensic Sci Int 2004
What It Found
- The validation reports no cross-reaction with Propoxyphene at 1 or 10 mg/L.
Keep in Mind
- The IDS assay was evaluated in human urine, blood and hair.
- The abstract does not separately assign a challenge matrix for each compound.
- It does not exclude a result on other buprenorphine reagents.
Test Studied
- IDS One-Step buprenorphine ELISA
Sulfamethoxazole
Source Hughey and Colby, Clin Chem 2019
What It Found
- An apparent association in medical records was investigated by testing the two ingredients of trimethoprim/sulfamethoxazole separately.
- Trimethoprim reacted but sulfamethoxazole did not.
Keep in Mind
- The combination remains searchable under trimethoprim.
- A negative single-ingredient challenge has only reagent-specific scope.
Test Studied
- Thermo CEDIA buprenorphine, 5 ng/mL